Patent intelligence · US
US 6723695
CTL epitopes from EBV
CTL epitopes from EBV
Patent details — US 6723695
- Jurisdiction
- US
- Status
- expired
- Grant date
- Apr 20, 2004
- Expiration
- Apr 15, 2024
- Claims
- 17
- CPC classes
- A61K, A61K39/00, A61K40/11, A61K40/46
Quick answer
US 6723695 (CTL epitopes from EBV) is held by Commonwealth Scientific and Industrial Research Organisation of Limestone Avenue. Status: expired. Granted Apr 20, 2004. Expires Apr 15, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 17
- CPC classes
- A61K, A61K39/00, A61K40/11, A61K40/46, A61P, A61P31/12
Frequently asked questions
What is US patent 6723695?
US 6723695 (CTL epitopes from EBV) is held by Commonwealth Scientific and Industrial Research Organisation of Limestone Avenue. Status: expired. Granted Apr 20, 2004. Expires Apr 15, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6723695?
Commonwealth Scientific and Industrial Research Organisation of Limestone Avenue is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 6723695 expire?
Our index shows an expiration date of Apr 15, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.